<DOC>
	<DOCNO>NCT02117999</DOCNO>
	<brief_summary>The purpose present Randomized Clinical Trial ( RCT ) compare efficacy safety transepithelial corneal cross-linking use iontophoresis ( T-ionto CL ) treat progressive keratoconus comparison standard cross-linking ( standard CL ) .</brief_summary>
	<brief_title>Transepithelial Corneal Cross-linking Using Iontophoresis</brief_title>
	<detailed_description>Keratoconus progressive corneal ecstatic disease cause visual impairment induce irregular astigmatism corneal opacity . This disorder typically begin second decade life , severe form , may need corneal transplantation . Corneal cross-linking procedure intend halt keratoconus progression . It create link stromal protein order stiffen corneal tissue . Standard CL include epithelial removal stroma soak dextran-enriched 0.1 % riboflavin solution 30 minute expose ultraviolet-A radiation use 3mW/cm2 lamp 30 minute . Epithelial debridement expose cornea risk side effect , pain first two post-operative day , temporary loss visual acuity first three month , serious complication infection stromal opacity due corneal scar . Iontophoresis non invasive technique weak electric current use enhance penetration hypotonic 0.1 % riboflavin-5-phosphate solution corneal stroma intact epithelium . After iontophoresis , corneal tissue irradiate use 10 mW/cm2 9 minute ( T-ionto CL ) . From previous experimental work ( Lombardo M. et al . JCRS 2014 JCRS 2015 ) , investigator provide evidence TCCionto increase stiffness human cornea result almost comparable standard CL . The new procedure thus hold promise effective standard procedure minimize related risk . It object present clinical trial randomize patient progressive keratoconus T-ionto CL standard CL compare efficacy safety treatment .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<criteria>Diagnosis progressive keratoconus Anterior corneal curvature steeper 61 D ; central corneal thickness &lt; 400 um corneal scarring ; descemetocele ; history herpetic keratitis ; Concomitant eye disease ; Inflammatory eye disease ; Glaucoma ; Cataract ; Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>corneal cross-linking</keyword>
	<keyword>transepithelial corneal cross-linking</keyword>
	<keyword>iontophoresis</keyword>
	<keyword>progressive keratoconus</keyword>
</DOC>